Covered recipient · General Payments record
TAMARA ZACH
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology with Special Qualifications in Child Neurology
General Payments · PY2018–2024
$3,927.61
- Reported across 247 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $820.34 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $511.16 | 21 |
| LivaNova USA, Inc. | $64.98 | 2 |
| JAZZ PHARMACEUTICALS INC. | $63.87 | 3 |
| ACADIA Pharmaceuticals Inc | $45.79 | 2 |
| Sumitomo Pharma America, Inc. | $34.90 | 2 |
| AQUESTIVE THERAPEUTICS, INC. | $27.22 | 1 |
| Neurelis, Inc. | $19.91 | 1 |
| Sarepta Therapeutics, Inc. | $19.03 | 1 |
| Biogen, Inc. | $18.23 | 1 |
| Marinus Pharmaceuticals, Inc. | $15.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $20.37 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147998215 | CMS |
| ACADIA Pharmaceuticals Inc | $25.42 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147998217 | CMS |
| AQUESTIVE THERAPEUTICS, INC. | $27.22 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146436755 | CMS |
| Biogen, Inc. | $18.23 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104823554 | CMS |
| JAZZ PHARMACEUTICALS INC. | $25.56 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150240256 | CMS |
| JAZZ PHARMACEUTICALS INC. | $16.24 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150240254 | CMS |
| JAZZ PHARMACEUTICALS INC. | $22.07 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150240252 | CMS |
| LivaNova USA, Inc. | $45.47 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152793289 | CMS |
| LivaNova USA, Inc. | $19.51 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152793393 | CMS |
| Marinus Pharmaceuticals, Inc. | $15.25 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141324698 | CMS |
| Neurelis, Inc. | $19.91 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145659199 | CMS |
| Sarepta Therapeutics, Inc. | $19.03 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126540599 | CMS |
| Sumitomo Pharma America, Inc. | $17.45 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148938905 | CMS |
| Sumitomo Pharma America, Inc. | $17.45 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148938907 | CMS |
| UCB, Inc. | $6.65 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066939 | CMS |
| UCB, Inc. | $8.14 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066941 | CMS |
| UCB, Inc. | $33.69 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066943 | CMS |
| UCB, Inc. | $9.51 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066945 | CMS |
| UCB, Inc. | $5.59 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066947 | CMS |
| UCB, Inc. | $43.08 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066949 | CMS |
| UCB, Inc. | $12.62 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066951 | CMS |
| UCB, Inc. | $8.56 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066953 | CMS |
| UCB, Inc. | $3.80 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066955 | CMS |
| UCB, Inc. | $21.79 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066957 | CMS |
| UCB, Inc. | $24.93 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066959 | CMS |
| UCB, Inc. | $39.06 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066961 | CMS |
| UCB, Inc. | $39.98 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066963 | CMS |
| UCB, Inc. | $115.63 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066965 | CMS |
| UCB, Inc. | $8.82 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066967 | CMS |
| UCB, Inc. | $6.62 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066969 | CMS |
| UCB, Inc. | $31.67 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066971 | CMS |
| UCB, Inc. | $7.55 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066973 | CMS |
| UCB, Inc. | $45.69 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066975 | CMS |
| UCB, Inc. | $29.22 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066977 | CMS |
| UCB, Inc. | $8.56 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143066979 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.